D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 100 Citations 39,209 349 World Ranking 3708 National Ranking 159

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

Kenneth Aldape mainly focuses on Cancer research, Glioma, Pathology, Internal medicine and Oncology. His research integrates issues of Cancer, DNA methylation, Immunology, Molecular biology and PTEN in his study of Cancer research. His DNA methylation research includes elements of Methylation, Epigenetics and ATRX.

His Glioma research is multidisciplinary, incorporating perspectives in Brain tumor, Regulation of gene expression, Gene and IDH1. His biological study spans a wide range of topics, including Survival analysis, Central nervous system disease, Astrocytoma and Epidermal growth factor receptor. His study in Oncology is interdisciplinary in nature, drawing from both Clinical trial, Phases of clinical research and Radiation therapy, Surgery, Temozolomide.

His most cited work include:

  • Comprehensive genomic characterization defines human glioblastoma genes and core pathways (5484 citations)
  • The Somatic Genomic Landscape of Glioblastoma (2550 citations)
  • Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis (2280 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Cancer research, Internal medicine, Glioma, Oncology and Pathology. As a part of the same scientific family, he mostly works in the field of Cancer research, focusing on DNA methylation and, on occasion, Methylation and Epigenetics. His Internal medicine research is multidisciplinary, incorporating elements of Surgery and Glioblastoma.

His Glioma study incorporates themes from IDH1 and Bioinformatics. His work in the fields of Progression-free survival overlaps with other areas such as Hazard ratio. His Pathology study combines topics in areas such as Angiogenesis, Survival analysis and Epidermal growth factor receptor.

He most often published in these fields:

  • Cancer research (35.24%)
  • Internal medicine (30.22%)
  • Glioma (28.55%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (35.24%)
  • Oncology (27.72%)
  • Internal medicine (30.22%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cancer research, Oncology, Internal medicine, Glioma and DNA methylation. His work deals with themes such as Cancer, Methylation, Mutant, Lung and Meningioma, which intersect with Cancer research. His Oncology research is multidisciplinary, relying on both Oligodendroglioma, Clinical trial and Glioblastoma, Temozolomide.

When carried out as part of a general Internal medicine research project, his work on Survival rate and Clinical endpoint is frequently linked to work in Hazard ratio and In patient, therefore connecting diverse disciplines of study. His Glioma research includes themes of Wild type, Isocitrate dehydrogenase and IDH1. His DNA methylation research integrates issues from Epigenetics and Pathology.

Between 2017 and 2021, his most popular works were:

  • DNA methylation-based classification of central nervous system tumours (733 citations)
  • Pan-cancer analysis of whole genomes (538 citations)
  • cIMPACT-NOW Update 3: Recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV” (228 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Kenneth Aldape focuses on Internal medicine, Oncology, Glioma, Cancer research and Meningioma. In the subject of general Internal medicine, his work in Temozolomide, Survival rate and Clinical trial is often linked to Hazard ratio, thereby combining diverse domains of study. His Oncology research incorporates elements of Glioblastoma, Methylation, DNA methylation, Radiation therapy and Oligodendroglioma.

His DNA methylation study integrates concerns from other disciplines, such as Pathological, Bioinformatics, Molecular evolution, Central nervous system and Telomere. The study incorporates disciplines such as Phenotype, IDH1, Stem cell, O-6-methylguanine-DNA methyltransferase and Epigenetics in addition to Glioma. His Cancer research research incorporates themes from Wild type, Regulation of gene expression, Gene, Ubiquitin ligase and MAPK/ERK pathway.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Roger McLendon;Allan Friedman;Darrell Bigner;Erwin G. Van Meir.
Nature (2008)

5348 Citations

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

Heidi S. Phillips;Samir Kharbanda;Ruihuan Chen;William F. Forrest.
Cancer Cell (2006)

2890 Citations

The Somatic Genomic Landscape of Glioblastoma

Cameron W. Brennan;Roel G W Verhaak;Aaron McKenna;Benito Campos.
Cell (2013)

2823 Citations

Comprehensivemolecular characterization of clear cell renal cell carcinoma

Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler.
Nature (2013)

2701 Citations

Comprehensive molecular characterization of urothelial bladder carcinoma

John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang.
Nature (2014)

2525 Citations

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert;James J. Dignam;Terri S. Armstrong;Terri S. Armstrong;Jeffrey Scott Wefel.
The New England Journal of Medicine (2014)

2085 Citations

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.

Houtan Noushmehr;Daniel J. Weisenberger;Kristin Diefes;Heidi S. Phillips.
Cancer Cell (2010)

2045 Citations

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

Daniel J. Brat;Roel G.W. Verhaak;Kenneth D. Aldape;W. K.Alfred Yung.
The New England Journal of Medicine (2015)

1955 Citations

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Dominik Sturm;Hendrik Witt;Hendrik Witt;Volker Hovestadt;Dong Anh Khuong-Quang.
Cancer Cell (2012)

1438 Citations

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

Michele Ceccarelli;Floris P Barthel;Tathiane M Malta;Thais S Sabedot.
Cell (2016)

1204 Citations

Editorial Boards

Neuro-Oncology
(Impact Factor: 13.029)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Kenneth D. Aldape

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 349

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 311

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 277

Michael Weller

Michael Weller

University of Zurich

Publications: 249

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 237

Felix Sahm

Felix Sahm

University Hospital Heidelberg

Publications: 187

David Capper

David Capper

Humboldt-Universität zu Berlin

Publications: 179

David A. Reardon

David A. Reardon

Harvard University

Publications: 173

Timothy F. Cloughesy

Timothy F. Cloughesy

University of California, Los Angeles

Publications: 169

David T. W. Jones

David T. W. Jones

German Cancer Research Center

Publications: 167

Keith L. Ligon

Keith L. Ligon

Harvard University

Publications: 145

Guido Reifenberger

Guido Reifenberger

Heinrich Heine University Düsseldorf

Publications: 143

Jeremy N. Rich

Jeremy N. Rich

University of Pittsburgh

Publications: 138

Gad Getz

Gad Getz

Broad Institute

Publications: 136

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 132

Tao Jiang

Tao Jiang

Capital Medical University

Publications: 129

Something went wrong. Please try again later.